Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.
about
Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag proteinHIV type 1 Gag as a target for antiviral therapyLipids and membrane microdomains in HIV-1 replicationThe Structure of Myristoylated Mason-Pfizer Monkey Virus Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Its Membrane BindingTrio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayersBasic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.Novel approaches to inhibiting HIV-1 replication.Protein targeting to exosomes/microvesicles by plasma membrane anchorsThe Role of Lipids in Retrovirus Replication.Roles played by acidic lipids in HIV-1 Gag membrane bindingPhosphoinositides direct equine infectious anemia virus gag trafficking and release.Oligomerization of a retroviral matrix protein is facilitated by backbone flexibility on nanosecond time scaleAssembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.Determination of the structures of symmetric protein oligomers from NMR chemical shifts and residual dipolar couplings.Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 GagMolecular determinants that regulate plasma membrane association of HIV-1 GagStructural and molecular determinants of HIV-1 Gag binding to the plasma membrane.The role of ITCH protein in human T-cell leukemia virus type 1 release.NMR structure of the myristylated feline immunodeficiency virus matrix protein.Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly.15N-1H scalar coupling perturbation: an additional probe for measuring structural changes due to ligand binding.Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.Equine Infectious Anemia Virus Gag Assembly and Export Are Directed by Matrix Protein through trans-Golgi Networks and Cellular Vesicles.Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.Using NMR to distinguish viscosity effects from nonspecific protein binding under crowded conditions.Retroviral matrix and lipids, the intimate interaction.Protein conformational switches: from nature to design.Interaction of Mason-Pfizer monkey virus matrix protein with plasma membrane.The roles of lipids and nucleic acids in HIV-1 assemblyRole of Gag and lipids during HIV-1 assembly in CD4(+) T cells and macrophages.The phospholipid code: a key component of dying cell recognition, tumor progression and host-microbe interactionsRous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.Defining the epitope region of a peptide from the Streptomyces coelicolor phosphoenolpyruvate:sugar phosphotransferase system able to bind to the enzyme IInvolvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.Phosphoinositide Binding Inhibits Actin Crosslinking and Polymerization by Palladin.The Mechanism of Budding of Retroviruses From Cell Membranes.Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.
P2860
Q24609231-C575378A-3E45-44CD-8287-DE4CDFBEA635Q24614498-3DC7920A-8B37-4485-8F63-92BF2742B1D5Q27489393-C05ACB7C-0580-46A0-818B-2331A13CC424Q27671147-F8B76275-13E6-4B05-8885-C69AA05F28CDQ27676343-3691742E-20BF-414B-92AE-610BFEF0DB77Q30540433-FCA445E1-70A4-4C2F-AD93-6392C52ED74FQ33624690-1B35D223-C7FC-473A-A1A5-BC71079DF1DBQ33814187-1AE54D03-2B22-4BAF-9797-0F447ED7415EQ34080779-8A871958-9C79-4E87-856E-7CD9BB7B4240Q34615838-B6C122A8-4B90-4F7C-8EE1-530567464AB6Q34723209-019EB55D-A835-4EA4-80B2-062422C7EA24Q34734018-A099E2AA-8A02-4F42-9D29-F7339AC7738DQ34742397-259D25E6-4FB9-46A2-84BB-27FD16931A31Q34823306-F95733D9-3494-439F-94EC-2CB6B0A0CD45Q35072137-7A30FC74-2F7D-4EEF-BD5D-00C7398595ACQ35076588-05F9703C-5B91-4494-83E7-3356A88152C2Q35113734-2AC82C4F-EF30-4B5A-8941-E949E533E5C4Q35199166-15EA770B-DCD3-43DC-9D94-4F306FC71164Q35213144-E0C0B4A5-7D6B-4BCA-8413-2E16ACF827ABQ35675988-AEFCBCF5-2332-4CE2-AF27-3C85A29F0C78Q35761675-320EC6B3-1265-4D4C-933F-837FDCEAB85DQ36443324-DD2A4F58-8F59-428D-9839-15B1F9EB1DD8Q36483275-5D2185EE-5738-4A03-BB99-62CA653BE106Q36524040-E09E082F-E924-425B-9E6E-6B4E1328A840Q36812591-A5F15C7E-01DF-40E0-9F02-2396881017D8Q37104100-AD4A559C-593E-4434-B25F-F6D51977A074Q37850839-71331411-2A7F-4FB9-BB3B-6A4D71957D32Q38017957-C31EB974-D9A9-48D1-925A-7BA231C24493Q38183384-9D8F8E97-A069-44DB-A0C9-DC00BECAD440Q38219405-4E723E49-1DD5-416A-AE83-842F1AF3BD8FQ38227871-015A718D-C3A9-4A4D-BE56-D225C98AEFB9Q38602808-B5AD8A87-DE89-4F55-AEC8-D4A02B9B4C8EQ38631942-265DD5EA-A179-42FB-8352-C42DB0CC78D3Q40768851-99B7C70E-FCA0-4615-8264-F3029E34E755Q41712949-4E8AF5B2-F1D4-48AC-8B7A-8A43D7A779E0Q42336468-9A29001B-070D-436E-83E6-DA61A06078A7Q42593601-5D6A7763-5012-45FD-8992-6BD4C8E2731CQ42947265-671DF80C-7B5A-4502-AACF-B4E899D79EFA
P2860
Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Solution NMR characterizations ...... and its interaction with PIP2.
@ast
Solution NMR characterizations ...... and its interaction with PIP2.
@en
type
label
Solution NMR characterizations ...... and its interaction with PIP2.
@ast
Solution NMR characterizations ...... and its interaction with PIP2.
@en
prefLabel
Solution NMR characterizations ...... and its interaction with PIP2.
@ast
Solution NMR characterizations ...... and its interaction with PIP2.
@en
P2093
P2860
P356
P1433
P1476
Solution NMR characterizations ...... and its interaction with PIP2.
@en
P2093
Carol Carter
Fadila Bouamr
Grzegorz Piszczek
Indra Bachtiar
Nico Tjandra
P2860
P304
P356
10.1021/BI701984H
P407
P577
2008-01-26T00:00:00Z